Entrada Therapeutics Inc.

NASDAQ: TRDA · Real-Time Price · USD
5.29
0.04 (0.76%)
At close: Aug 15, 2025, 3:59 PM
5.27
-0.28%
After-hours: Aug 15, 2025, 04:10 PM EDT

Entrada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-43.1M -17.35M 1.13M -14.03M 55.03M 23.5M -9.54M 35.46M -25.93M -6.67M -24.63M -25.14M -23.18M -21.67M -18.45M -14.43M -9.9M -8.38M
Depreciation & Amortization
1.03M 946K 992K 937K 910K 934K 736K 834K 730K 541K 525K 514K 466K 390K 364K 302K 252K 199K
Stock-Based Compensation
5.05M 5.09M 4.7M 4.86M 4.62M 3.73M 3.84M 3.4M 3.12M 2.75M 2.88M 2.71M 2.51M 1.79M 1.46M 578K 326K 164K
Other Working Capital
25.58M -25.58M -37.69M -17.57M -87.42M 20.65M -2.62M -60.97M -6.94M 206.48M -10.57M -2.63M 510K -3.71M -2.81M -758K 914K -51K
Other Non-Cash Items
-18.32M -1.34M -2.51M -3.21M -2.26M -2.04M 1.76M -1.85M -1.69M -237K -103K -30K 142K 142K -79K 153K n/a n/a
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
25.85M -25.85M -35.92M -12.82M -18.47M -51.65M 2.95M -62.33M -11.32M 207.01M -5.98M -5.54M 2.05M -1.65M -3.84M -678K 1.41M -319K
Operating Cash Flow
-29.49M -38.51M -31.61M -24.27M 39.83M -25.52M -4.01M -24.49M -35.09M 203.4M -27.3M -27.48M -18.01M -20.99M -20.54M -14.07M -7.91M -8.34M
Capital Expenditures
-275K -1.14M -635K -639K -1.05M -838K -976K -1.45M -1.52M -1.67M -708K -810K -775K -594K -1.32M -806K -1.54M -908K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -152.8M 2.29M 111.73M 38.78M n/a 9.32M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-16.55M -80.02M -64.5M -165.59M -110.69M -96.94M -88.52M -76.79M -140.12M -101.78M n/a -39.32M n/a -182.65M n/a n/a n/a n/a
Sales Maturities Of Investments
50.63M 85.95M 118.5M 83.31M 87.36M 123.92M 108.54M 74.5M 28.39M 63M 19.5M 30M 25M 1.71M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -23.34M 26.98M 20.02M -2.29M -111.73M -38.78M 19.5M -9.32M 25M n/a n/a n/a n/a n/a
Investing Cash Flow
33.8M 4.78M 53.37M -82.93M -24.38M 26.15M 19.04M -3.74M -113.26M -40.44M 18.79M -10.13M 24.23M -181.53M -1.32M -806K -1.54M -908K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
317K n/a n/a n/a n/a n/a 443K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 350K 1.4M 381K 101.37M 206K 690K 368K 443K 129K 358K 60K 11K 50K 190.75M 106K 215K 137K
Financial Cash Flow
337K 350K 1.4M -11K 101.37M 206K 690K 368K 443K 19.54M 358K 60K 11K 50K 190.75M 106K 215K 116.39M
Net Cash Flow
4.64M -33.37M 23.16M -107.2M 116.82M 834K 15.72M -27.86M -147.91M 182.49M -8.15M -37.56M 6.23M -202.47M 168.89M -14.78M -9.24M 107.14M
Free Cash Flow
-29.76M -39.65M -32.24M -24.91M 38.79M -26.36M -4.99M -25.94M -36.61M 201.73M -28.01M -28.29M -18.78M -21.59M -21.86M -14.88M -9.45M -9.24M